Fig. 6

Validation group of HOXD9 in one set of HCC tissue microarrays. A Immunohistochemistry staining of HOXD9 in HCC tissues with MVI and without MVI. B Scatter plots reflecting the HOXD9 staining intensity in HCC tissues with MVI (n = 140) and without MVI (n = 120); ***, P < 0.001. C High HOXD9 expression correlated with lower disease-free survival in HCC patients (HOXD9 high, n = 70; HOXD9 low, n = 70), P = 0.002. D High HODX9 expression correlated with lower overall survival in HCC patients (HOXD9 high, n = 70; HOXD9 low, n = 70), P = 0.005